We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App





Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015

By Paul Mills
Posted on 24 May 2016
A breakthrough technology now enables the manufacture of plastic exterior components with complete interior coverage of pure glass. More...
Attendees of the 2015 AACC Meeting & Clinical Lab Expo (July 26–30; Atlanta, GA, USA) are invited to visit Booth 3615 to learn about how the broad range of products envisioned from the application of this technology could provide numerous benefits, including for clinical science.

“This breakthrough will allow us to provide products that have the best of both worlds: the lightweight, break resistant properties of plastic with the barrier qualities and inert inner surface of pure glass,” said Wayne Brinster, president and CEO of Wheaton (Millville, NJ, USA), a leading provider of innovative plastic- and glass-based solutions for research, diagnostic, and specialty pharmaceutical industries. “For 126 years Wheaton has been an innovator in glass as well as plastic for laboratories. Customers look to us to solve their needs and this technology will allow us to develop purpose-built products that blend the features of both glass and plastic into a single innovative solution,” he added.

The technology is broadly applicable across the bulk of the company’s product range. Benefits of a pure glass interior include the elimination of compounds from the container contaminating the contents as occasionally occurs with plastic products, while also providing an interior surface with less vapor transmission and higher resistance to solvents. This is combined with the benefit of the lightweight plastic exterior protecting the glass from cracking and breakage.

“We understand that there are many applications where using a plastic product or a glass product are appropriate,” said Mr. Brinster, “But we also know that there are applications where having both materials in one product has long been needed. These premium products will fill those needs as none have been available until now. The tooling needed for broad production of the glass and plastic products is being built now and we expect to begin delivery of these products to customers in the fourth quarter this year.”

Related Links:

Wheaton
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.